Abg-wtt Global Life Science Capital Partners Gp Ltd is an investment fund managing more than $30 billion ran by Fan Yu. There are currently 3 companies in Yu’s portfolio. The largest investments include Cg Oncology Inc and Rapid Micro Biosystems Inc, together worth $29.6 billion.
As of 7th August 2024, Abg-wtt Global Life Science Capital Partners Gp Ltd’s top holding is 915,501 shares of Cg Oncology Inc currently worth over $28.9 billion and making up 96.4% of the portfolio value.
In addition, the fund holds 1,038,296 shares of Rapid Micro Biosystems Inc worth $685 million.
The third-largest holding is Pulmonx Corp worth $382 million.
Currently, Abg-wtt Global Life Science Capital Partners Gp Ltd's portfolio is worth at least $30 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Abg-wtt Global Life Science Capital Partners Gp Ltd office and employees reside in Hong Kong, Hong Kong. According to the last 13-F report filed with the SEC, Fan Yu serves as the Director at Abg-wtt Global Life Science Capital Partners Gp Ltd.
The two most similar investment funds to Abg-wtt Global Life Science Capital Partners Gp Ltd are Aberdeen Asset Management Plc/uk and Csu Producer Resources. They manage $30 billion and $30 billion respectively.
Abg-wtt Global Life Science Capital Partners Gp Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 1.3% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $256 million.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Cg Oncology Inc |
No change
915,501
|
$28,902,367,000 | 96.44% |
| Rapid Micro Biosystems Inc |
No change
1,038,296
|
$685,275,000 | 2.29% |
| Pulmonx Corp |
No change
60,204
|
$381,693,000 | 1.27% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||